Cristina Tzilinis
Gynecology · Naples, FLNPI 1073628848
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 93.2% of the total across 86 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. 24 manufacturers reported payments, led by AbbVie at 33.5% of the total. Reporting peaked in 2019 at $550 and has fallen 74.5% since, to $140 in 2025.
Across 86 payments — averaging $19.74 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AbbVie$569
- Amgen$163
- Hologic Sales And Service, LLC$140
- Therapeuticsmd, Inc.$138
- AMAG Pharmaceuticals, Inc.$84
- Pfizer$69
- plus $536 from 18 others
What the payments were for
- Food & beverage$1,58393%
- Education$1016%
- Gifts$141%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AbbVie(2 entities) | 24 | $569 |
| Amgen | 4 | $163 |
| Hologic Sales And Service, LLC | 7 | $140 |
| Therapeuticsmd, Inc. | 8 | $138 |
| AMAG Pharmaceuticals, Inc. | 5 | $84 |
| Pfizer | 4 | $69 |
| Millicent US Inc | 4 | $66 |
| Exeltis, USA Inc. | 3 | $58 |
| Merck | 3 | $43 |
| Evofem Biosciences, Inc. | 2 | $42 |
| Mayne Pharma Commercial LLC | 3 | $41 |
| Ascend Therapeutics US, LLC | 3 | $38 |
| Avion Pharmaceuticals | 3 | $37 |
| Bayer | 2 | $31 |
| Lupin Inc. | 2 | $30 |
| Duchesnay USA Incorporated | 1 | $21 |
| Mycovia Pharmaceuticals, Inc. | 1 | $20 |
| Sumitomo Pharma America, Inc. | 1 | $20 |
| Organon | 1 | $17 |
| Axonics, Inc. | 1 | $17 |
| Laborie Medical Technologies Corp. | 1 | $17 |
| Astellas Pharma US Inc | 1 | $16 |
| Agile Therapeutics, Inc. | 1 | $12 |
| Lilly USA, LLC | 1 | $11 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$1,698 in reported general payments places this provider in the 70th percentile of 290 gynecology providers in Florida.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Estradiol | 61 | $4,641 |
| ProgesteroneProgesterone, Micronized | 84 | $3,451 |
| Estradiol (Twice Weekly)Estradiol | 22 | $2,755 |
| Estradiol (Once Weekly)Estradiol | 13 | $1,433 |
| ValacyclovirValacyclovir Hcl | 15 | $1,111 |
| Norethindrone Acetate | 11 | $140 |
Paid to pharmacies, not to this prescriber.
Other gynecology in Naples
- Rafael HaciskiNaples$3K
- Aileen CaceresKissimmee$406K
- Parveen VahoraNew Port Richey$327K
- James KondrupVenice$310K
- Andrea GallowayThe Villages$252K
- Jessica VaughtOrlando$129K
- Steven ChavoustieMiami$113K
- Marshall BovelskyMelbourne$52K
- Minda NeimarkFt Lauderdale$46K
- Meenakshi JainSt Petersburg$35K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.